Pediatric Nephrology, Dialysis and Transplantation Unit, Department of Woman's and Child's Health, University Hospital of Padua, Via Giustiniani 3, 35128, Padua, Italy.
Pediatr Nephrol. 2018 Apr;33(4):547-551. doi: 10.1007/s00467-017-3857-3. Epub 2017 Dec 7.
Peritoneal dialysis (PD) in infants represents one of the greatest challenges for pediatric nephrologists. Over recent years, positive outcome data described by several multicenter experiences and registry studies have increased the amount of information available to help determine whether to initiate a dialysis program in this high-risk patient population. There is no doubt that the rigorous implementation of strategies aimed at preventing infectious complications may have contributed to reducing the morbidity rate of these patients. However, the complex nature of infants with end-stage renal disease and the presence of multiple comorbidities still represent hallmarks that significantly impact on outcome. Although the rigorous application of improved scientific techniques can still contribute to enhancing PD results in infants, we have to acknowledge that the severity of illness in infants, especially at dialysis initiation, represents an undeniable and nonmodifiable factor.
婴儿腹膜透析(PD)是儿科肾脏病医生面临的最大挑战之一。近年来,多项多中心经验和注册研究描述的积极结果数据增加了可用信息的数量,以帮助确定是否在这一高危患者人群中启动透析计划。毫无疑问,严格实施旨在预防感染并发症的策略可能有助于降低这些患者的发病率。然而,终末期肾病婴儿的复杂性和多种合并症的存在仍然是显著影响预后的标志。尽管严格应用改进的科学技术仍然有助于提高婴儿 PD 的效果,但我们必须承认,婴儿的疾病严重程度,尤其是在开始透析时,是一个不可否认且不可改变的因素。